Navigation Links
PDL BioPharma Announces First Quarter 2009 Financial Results
Date:5/7/2009

of a number of humanized antibody products marketed today and also may receive royalty payments on additional humanized antibody products launched before patent expiry in late 2014. This press release and further information about PDL BioPharma, Inc. can be found at www.pdl.com.

Forward-looking Statements

This press release contains forward-looking statements, including regarding PDL's expectations with respect to its 2009 royalty revenues, expenses, net income and cash provided by operating activities.

Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from those, express or implied, in these forward-looking statements. Factors that may cause differences between current expectations and actual results include, but are not limited to, the following:

    --  The expected rate of growth in royalty-bearing product sales by PDL's
        existing licensees;
    --  The relative mix of royalty-bearing products manufactured and sold
        outside the U.S. versus manufactured or sold in the U.S.;
    --  The ability of our licensees to receive regulatory approvals to
        market and launch new
        royalty-bearing products and whether such products, if launched, will
        be commercially successful;
    --  Changes in any of the other assumptions on which PDL's projected
        royalty revenues are based;
    --  The outcome of pending litigation or disputes; and
    --  The failure of licensees to comply with existing license agreements,
        including any failure to pay royalties due.


Other factors that may cause PDL's actual results to differ materially from those expressed or implied in the forward-looking statements in this press release are discussed in PDL's filings with the SEC, including the "Risk Factors" sections
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Sinobiopharma Secures Rights to Seven Key Patents
2. China Biologic Products Receives $5.3 Million Order from Largest Biopharmaceutical Distributor in India
3. Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
4. Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
5. Helix BioPharma to Present at the BioFinance 2009 Conference
6. Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Chief Executive Officer
7. 2009 Prix Galien USA Now Accepting Nominations for Top Prize in Biopharmaceutical Research and Development
8. Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research
9. Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer as First True Automation-Friendly Osmometer for the Biopharmaceutical Industry
10. XTL Biopharmaceuticals Ltd. Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel
11. Sinobiopharma, Inc. Appoints New Director of Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014  Franciscan St. Anthony Health-Crown ... for respiratory monitoring outside the operating room, ... in embracing state-of-the-art patient safety technology. ... breathing and can alert medical caregivers when ... amount of carbon dioxide the patient is ...
(Date:7/10/2014)... Ceres, Inc . (Nasdaq: CERE ), an ... for the three months ended May 31, 2014 and ... reported that the company and its customers have made ... Brazil, which concluded in June, despite dry and hot ... part of the growing season. Yields of several of ...
(Date:7/10/2014)... disorders has been extremely challenging because there are many ... to cause disease. Now investigators reporting in the July ... Stem Cell describe a strategy that may help ... risk factors or environmental exposures to affect the development ... variant that may predispose individuals to schizophrenia. , ...
(Date:7/10/2014)... by researchers at the University of Illinois at ... governing the interplay of spin and heat at ... ultrafast spintronic devices for data storage and information ... well as spin-angular momentum. In a typical charge ... no spin current," explained David Cahill, a professor ...
Breaking Biology Technology:Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9New strategy could uncover genes at the root of psychiatric illnesses 2University of Illinois study advances limits for ultrafast nano-devices 2
... -- bioTheranostics, a bioMerieux company that develops ... announced today study results published in the next issue ... to the clinical validity and the clinical utility of ... in the determination of the origin of a tumor. ...
... 2011 Peloton Therapeutics, Inc., an early-stage cancer drug ... an $18 million Series A financing.  Led by The ... O,Donnell, Jr., the Series A funds supplement a recently ... Research Institute of Texas (CPRIT). Peloton officials ...
... 2011 The Raymond and Ruth Perelman ... announces the launching of a first-of-its-kind interdisciplinary ... diseases. The Center will bring together, without institutional ... orphan diseases: establishing dedicated research support facilities, translating ...
Cached Biology Technology:New Study Reports CancerTYPE ID Expands Tumor Type Coverage and Demonstrates Clinical Utility 2New Study Reports CancerTYPE ID Expands Tumor Type Coverage and Demonstrates Clinical Utility 3Peloton Therapeutics Completes $18 Million Series A Financing 2Peloton Therapeutics Completes $18 Million Series A Financing 3Penn Receives $10 Million to Create Center for Orphan Disease Research and Therapy 2
(Date:7/11/2014)... have set a "mouse TRAP" to capture the early ... study published in the Journal of Clinical Investigation ... called TRAP to extract cellular and genetic information from ... at the Rockefeller Institute for Medical Research in 2008, ... machinery, or ribosomes, of the cell type of interest. ...
(Date:7/11/2014)... 2014, Shenzhen, China Researchers from Salk Institute for ... first time evaluated the safety and reliability of ... developed a new method, TALEN-HDAdV, which could significantly ... cell (hiPSC). This study published online in ... foundation for stem cell-based gene therapy. , The ...
(Date:7/11/2014)... Researchers from Ume University, Sweden, have explored two ... the reaction sequence leading to the formation of ... been published in the scientific journal Nature ... improving present day synthetic catalysts for water oxidation, ... devices for the direct storage of solar energy ...
Breaking Biology News(10 mins):A new genome editing method brings the possibility of gene therapies closer to reality 2Molecular snapshots of oxygen formation in photosynthesis 2
... millipedes previously unknown in Australia has been discovered by ... of the widespread tropical family Pyrgodesmidae have been found among ... are not only widespread in Australia,s tropical and subtropical ... been published in the open access journal ZooKeys ...
... Trust and the Engineering and Physical Sciences Research Council ... initiative to find biomedical engineering solutions to challenging healthcare ... provide funding for a limited number of ground-breaking long-term ... are inadequate. Up to 10m over seven years is ...
... 29, 2012 The Crop Science Society of America (CSSA) ... during their Annual Meetings, Oct. 21-24, 2012 in Cincinnati, OH. ... professional achievements and meritorious service. Only 0.3 percent of the ... 2012 class of CSSA Fellows are: Marc C. ...
Cached Biology News:Millipede family added to Australian fauna 2£30 million boost for biomedical engineering research 2Crop Science Society of America presents 2012 class of fellows 2Crop Science Society of America presents 2012 class of fellows 3
... Agarose Spin Kit is an advanced system for isolating ... DNA can be used directly for any downstream application. ... is ready to use in 56 minutes Low ... for TAE and TBE gels No specialised equipment ...
... Spin Columns provide a rapid and simple method ... bp to 10 kb) from stained agarose gels ... excised from an agarose gel and loaded into ... the column are a series of membranes and ...
... Silica Bead Kit has been designed for recovery of ... Features Ultra fast protocol: DNA ... silica beads are easy to resuspend Bead uniformity ... pure DNA (suitable for PCR) DNA is eluted ...
... extraction of DNA fragments from 150 bp to > ... uses GelMelt solution to dissolve the gel slice, followed ... in a spin column format. After a wash step, ... spin column can bind up to 20 g DNA. ...
Biology Products: